Adverse Prognostic Impact of Perioperative Allogeneic Transfusion on Patients With Stage II/III Gastric Cancer

Gastric Cancer - Germany
doi 10.1007/s10120-014-0456-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prognostic Impact of Mutation Profiling in Patients With Stage II and III Colon Cancer

Scientific Reports
Multidisciplinary
2016English

Effect of Perioperative Blood Transfusion on Prognosis of Gastric Cancer

Annals of Cancer Research and Therapy
Cancer ResearchOncologyPharmacology
1992English

Decreased Expression of Eukaryotic Initiation Factor 3f Is an Adverse Prognostic Factor for Stage I–III Gastric Cancer

World Journal of Surgical Oncology
SurgeryOncology
2014English

Significance of the Glasgow Prognostic Score in Predicting the Postoperative Outcome of Patients With Stage III Gastric Cancer

Journal of Clinical Medicine
2019English

MicroRNA-9-5p-CDX2 Axis: A Useful Prognostic Biomarker for Patients With Stage II/III Colorectal Cancer

Cancers
Cancer ResearchOncology
2019English

Multidisciplinary Management of Stage II-III Gastric and Gastro-Oesophageal Junction Cancer

European Journal of Cancer
Cancer ResearchOncology
2020English

Perioperative Anemia and Transfusion in Colorectal Cancer Patients

Chirurgia (Bucharest, Romania : 1990)
Surgery
2019English

Desmopressin Use for Minimising Perioperative Allogeneic Blood Transfusion

2004English

HLA-DQB1*03 Genotype and Perioperative Blood Transfusion Are Not Conducive to the Prognosis of Patients With Gastric Cancer

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy